tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Ratios

Compare
247 Followers

NewAmsterdam Pharma Company Ratios

NAMS's free cash flow for Q4 2025 was $-0.84. For the 2025 fiscal year, NAMS's free cash flow was decreased by $ and operating cash flow was $-2.06K. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
7.88 7.88 8.08 6.95 13.26
Quick Ratio
7.88 7.88 8.08 6.95 13.26
Cash Ratio
5.71 5.71 7.22 6.82 12.97
Solvency Ratio
-2.37 -2.37 -2.25 -3.01 -0.47
Operating Cash Flow Ratio
-1.72 -1.72 -1.48 -2.83 0.30
Short-Term Operating Cash Flow Coverage
-1.09K -1.09K -644.57 0.00 0.00
Net Current Asset Value
$ 589.85M$ 589.85M$ 756.29M$ 288.09M$ 429.55M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
1.13 1.13 1.14 1.20 1.11
Debt Service Coverage Ratio
-1.78K -1.78K -981.65 -26.02 -77.83
Interest Coverage Ratio
0.00 0.00 0.00 -26.91 -12.39
Debt to Market Cap
<0.01 <0.01 <0.01 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 0.08 0.02
Net Debt to EBITDA
2.02 2.02 3.19 1.92 20.93
Profitability Margins
Gross Profit Margin
99.74%99.74%100.00%100.00%100.00%
EBIT Margin
-1077.83%-1077.83%-530.25%-1255.57%-21.76%
EBITDA Margin
-1076.86%-1076.86%-530.00%-1255.22%-21.75%
Operating Profit Margin
-1002.90%-1002.90%-386.91%-1298.56%-3.46%
Pretax Profit Margin
-905.74%-905.74%-530.25%-1255.57%-22.04%
Net Profit Margin
-905.74%-905.74%-530.25%-1255.76%-22.04%
Continuous Operations Profit Margin
-905.74%-905.74%-530.25%-1255.76%-22.04%
Net Income Per EBT
100.00%100.00%100.00%100.02%100.00%
EBT Per EBIT
90.31%90.31%137.05%96.69%636.32%
Return on Assets (ROA)
-26.49%-26.49%-27.94%-50.98%-4.73%
Return on Equity (ROE)
-27.47%-29.82%-31.89%-61.35%-5.26%
Return on Capital Employed (ROCE)
-33.02%-33.02%-23.27%-61.56%-0.80%
Return on Invested Capital (ROIC)
-33.01%-33.01%-23.26%-61.55%-0.80%
Return on Tangible Assets
-26.51%-26.51%-27.96%-51.00%-4.73%
Earnings Yield
-6.16%-5.08%-9.96%-19.28%-10.95%
Efficiency Ratios
Receivables Turnover
0.97 0.97 2.14 7.49 0.00
Payables Turnover
<0.01 <0.01 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
39.62 39.62 67.70 139.50 666.84
Asset Turnover
0.03 0.03 0.05 0.04 0.21
Working Capital Turnover Ratio
0.04 0.03 0.09 0.04 0.41
Cash Conversion Cycle
-55.12K -55.12K 170.67 48.73 0.00
Days of Sales Outstanding
375.53 375.53 170.67 48.73 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
55.49K 55.49K 0.00 0.00 0.00
Operating Cycle
375.53 375.53 170.67 48.73 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.29 -1.29 -1.68 -1.72 0.56
Free Cash Flow Per Share
-1.29 -1.29 -1.69 -1.72 0.55
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 0.98
Dividend Paid and CapEx Coverage Ratio
-600.74 -600.74 -235.96 -5.88K 48.26
Capital Expenditure Coverage Ratio
-600.74 -600.74 -235.96 -5.88K 48.26
Operating Cash Flow Coverage Ratio
-731.60 -731.60 -353.94 -2.35K 84.64
Operating Cash Flow to Sales Ratio
-6.57 -6.57 -3.48 -10.02 0.10
Free Cash Flow Yield
-4.45%-3.69%-6.57%-15.39%5.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-16.24 -19.69 -10.04 -5.19 -9.13
Price-to-Sales (P/S) Ratio
147.86 178.34 53.22 65.13 2.01
Price-to-Book (P/B) Ratio
4.84 5.87 3.20 3.18 0.48
Price-to-Free Cash Flow (P/FCF) Ratio
-22.48 -27.11 -15.23 -6.50 19.79
Price-to-Operating Cash Flow Ratio
-22.40 -27.16 -15.29 -6.50 19.38
Price-to-Earnings Growth (PEG) Ratio
-1.02 0.62 -0.53 -0.06 0.14
Price-to-Fair Value
4.84 5.87 3.20 3.18 0.48
Enterprise Value Multiple
-11.71 -14.54 -6.85 -3.26 11.68
Enterprise Value
2.84B 3.52B 1.65B 577.34M -260.87M
EV to EBITDA
-11.71 -14.54 -6.85 -3.26 11.68
EV to Sales
126.10 156.57 36.29 40.97 -2.54
EV to Free Cash Flow
-19.17 -23.80 -10.39 -4.09 -24.98
EV to Operating Cash Flow
-19.20 -23.84 -10.43 -4.09 -24.46
Tangible Book Value Per Share
5.97 5.97 8.02 3.51 22.66
Shareholders’ Equity Per Share
5.97 5.97 8.03 3.51 22.68
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 <0.01 >-0.01 0.00
Revenue Per Share
0.20 0.20 0.48 0.17 5.41
Net Income Per Share
-1.78 -1.78 -2.56 -2.15 -1.19
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.84 0.84 1.00 1.00 1.01
Research & Development to Revenue
6.30 6.30 3.32 11.31 0.84
SG&A to Revenue
4.72 4.72 1.55 2.67 0.19
Stock-Based Compensation to Revenue
2.02 2.64 0.74 1.74 0.04
Income Quality
1.97 0.00 0.66 0.80 -0.47
Currency in USD